Abstract
A model describing the response of the growth of single human cells in the absence and presence of the anti-cancer agent topotecan (TPT) is presented. The model includes a novel coupling of both the kinetics of TPT and cell cycle responses to the agent. By linking the models in this way, rather than using separate (disjoint) approaches, it is possible to illustrate how the drug perturbs the cell cycle. The model is compared to experimental in vitro cell cycle response data (comprising single cell descriptors for molecular and behavioural events), showing good qualitative agreement for a range of TPT dose levels.
| Original language | English |
|---|---|
| Pages (from-to) | 169-178 |
| Number of pages | 10 |
| Journal | Computer Methods and Programs in Biomedicine |
| Volume | 89 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2008 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cell cycle models
- Compartmental models
- Drug kinetics
- Topotecan
ASJC Scopus subject areas
- Software
Fingerprint
Dive into the research topics of 'A coupled drug kinetics-cell cycle model to analyse the response of human cells to intervention by topotecan'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS